FFA
INO icon

Farther Finance Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Farther Finance Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$135 Hold
111
– – ﹤0.01% 5937
2026
Q2 		$122 Buy
111
+75
+208% +$89 ﹤0.01% 5773
2026
Q1 		$63 Buy
36
+20
+125% +$33 ﹤0.01% 5556
2025
Q4 		$28 Hold
16
– – ﹤0.01% 5380
2025
Q3 		$37 Hold
16
– – ﹤0.01% 4883
2025
Q2 		$33 Hold
16
– – ﹤0.01% 4403
2025
Q1 		$24 Sell
16
-30
-65% -$60 ﹤0.01% 4184
2024
Q4 		$84 Buy
46
+10
+28% +$44 ﹤0.01% 3808
2024
Q3 		$208 Sell
36
-813
-96% -$6.71K ﹤0.01% 3640
2024
Q2 		$7.31K Sell
849
-1
-0.1% -$11 ﹤0.01% 2206
2024
Q1 		$11.1K Sell
850
-21
-2% -$181 ﹤0.01% 1716
2023
Q4 		$5.33K Hold
871
– – ﹤0.01% 1940
2023
Q3 		$4.07K Buy
871
+21
+2% +$116 ﹤0.01% 1584
2023
Q2 		$4.56K Hold
850
– – ﹤0.01% 1463
2023
Q1 		$8.37K Hold
850
– – ﹤0.01% 1171
2022
Q4 		$15.9K Buy
+850
New +$19.3K 0.01% 801

Other funds holding INO

GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

Farther Finance Advisors's INO Position: Q3 2026 in Review

Farther Finance Advisors held its Inovio Pharmaceuticals (INO) position steady in Q3 2026 at 111 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #5937.

Farther Finance Advisors first reported a position in INO in Q4 2022 and has held it in 16 quarters since. The position peaked at $15.9K in Q4 2022. 5 funds tracked by Wall St. Rank hold INO as of Q3 2026.

  • Farther Finance Advisors held 111 shares of Inovio Pharmaceuticals worth $135 as of Q3 2026.
  • Farther Finance Advisors left its Inovio Pharmaceuticals share count unchanged in Q3 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5937 holding.
  • Farther Finance Advisors first reported a position in Inovio Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Inovio Pharmaceuticals position peaked at $15.9K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.